A Study on Bioequivalence of Cabergoline Tablets in Human Body
A Study on Bioequivalence of Cabergoline Tablets in Human Body
Active, not recruiting · NCT07008417 · Registry updated 2025-11-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study on Bioequivalence of Cabergoline Tablets in Human Body | brain disorder, central nervous system disorder, endocrine system disorder, hyperpituitarism, hyperprolactinemia, hypothalamic disorder, nervous system disorder, pituitary gland disorder | Active, not recruiting | Phase 1 | 2025-11-17 | NCT07008417 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Changchun GeneScience Pharmaceutical Co., Ltd. | 50 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zhejiang Xiaoshan Hospital | Hangzhou | China | 1 |